|
Market Closed -
Oslo Bors
10:45:00 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.7000 NOK | +40.56% |
|
0.00% | -49.28% |
| 09-03 | EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
Business description: EXACT Therapeutics

Number of employees: 11
Sales by Activity: EXACT Therapeutics
| Fiscal Period: December | 2021 (NOK) | 2022 (NOK) | 2023 (NOK) | 2024 (NOK) | 2025 (NOK) |
|---|---|---|---|---|---|
Research and Development of Acoustic Cluster Therapy (ACT) | 52K | 455K | 4.46K | - | 59K |
Geographical breakdown of sales: EXACT Therapeutics
| Fiscal Period: December | 2021 (NOK) | 2022 (NOK) | 2023 (NOK) | 2024 (NOK) | 2025 (NOK) |
|---|
Executive Committee: EXACT Therapeutics
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 2022-06-05 |
Svein Kvåle
COO | Chief Operating Officer | - | 2011-12-31 |
John Edminson
DFI | Director of Finance/CFO | - | 2022-09-30 |
Ragnar Bendiksen
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Amir Snapir
CTO | Chief Tech/Sci/R&D Officer | - | 2022-09-20 |
Composition of the Board of Directors: EXACT Therapeutics
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2018-06-21 | |
Anders Wold
CHM | Chairman | - | 2022-06-07 |
| Director/Board Member | 59 | - | |
Leiv Askvig
BRD | Director/Board Member | 69 | - |
Company details: EXACT Therapeutics

Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +40.56% | 0.00% | -62.77% | -94.62% | 4.7M | ||
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | ||
| +1.76% | +2.10% | +12.10% | +81.21% | 54.55B | ||
| -0.94% | +0.99% | +10.45% | +102.18% | 53.59B | ||
| +2.76% | +0.87% | +27.92% | +57.51% | 44.75B | ||
| +2.00% | -3.39% | +17.83% | +100.08% | 41.62B | ||
| +1.34% | -2.86% | +224.43% | +928.45% | 39.91B | ||
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | ||
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | ||
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | ||
| Average | +8.14% | -0.01% | +40.66% | +137.22% | 38.04B | |
| Weighted average by Cap. | +3.21% | -0.29% | +47.59% | +161.57% |
- Stock Market
- Stocks
- EXTX Stock
- Company EXACT Therapeutics
Select your edition
All financial news and data tailored to specific country editions

















